- Graduate School - University of North Carolina at Greensboro (1978-1983), Psychology
- Internship - University of Mississippi and VA Center Consortium (1983-1984), Clinical Psychology
- Internship - Beck Institute for Cognitive Therapy and Research (2000-2001), Cognitive Therapy
Robin Jarrett, Ph.D.
- Elizabeth H. Penn Professorship in Clinical Psychology
Robin Jarrett, Ph.D., is a Licensed Psychologist with the Texas State Board of Examiners of Psychologists. Dr. Jarrett is a licensed psychologist who is board certified in clinical psychology. Her research and clinical expertise is in promoting health and wellness, particularly for patients with mood and related disorders. She specializes in short-term, evidenced-based psychotherapy and focuses on cognitive behavioral therapy.
In the Department of Psychiatry at UT Southwestern, Dr. Jarrett collaborates on research, treats patients, teaches, and supervises clinical and/or research activities of trainees. Since 1989 Dr. Jarrett has directed the Psychosocial Research and Depression Clinic where the National Institute of Mental Health (NIMH) has funded her research group across decades. She welcomes collaborators and trainees dedicated to understanding the role of psychosocial factors in the course of health and illness, particularly in mood and related disorders.
A partial listing of Dr. Jarrett’s publications can be found below and a more complete listing is available to interested readers at here.
TX License #23167; Expires 10/31/2021
- American Board of Professional Psychology (ABPP) (2017-2021)
- American Psychological Association (APA) Society of Clinical Psychology Mentorship Program (2017-2019)
- Editorial Board: Psychotherapy and Psychosomatics (2017-2021)
- Association for Psychological Science (APS) (2010-2021)
- Editorial Board: Journal of Consulting and Clinical Psychology (2004-2016)
- Dallas Psychological Association (DPA) (1993-2021)
- Reviewers Reserve [NIMH] (1990-2021)
- Texas Psychological Association (TPA) (1990-2021)
- International Association for Cognitive Psychotherapy (1989-2017)
- American Psychological Association (APA) (1984-2021)
- Association for Behavioral and Cognitive Therapy (ABCT) (1978-2021)
- Distinguished Psychologist
- Dallas Psychological Association 2018, Fellow
- Association for Behavioral and Cognitive Therapies 2015-2021, Fellow
- American Psychological Association 2014-2021, Fellow
- Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) 2006, Fellow
- Elizabeth H. Penn Professorship in Clinical Psychology; The University of Texas Southwestern Medical Center 2004-2021
- Fourjay Scholar; The Fourjay Foundation, The Beck Institute, Extramural Training Program 2000
- Diplomate and Founding Fellow; Academy of Cognitive Therapy 1999-2021
- Principal Investigator with career awards; Funded by the National Institute of Mental Health
Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry.
Kappelmann N, Rein M, Fietz J, Mayberg HS, Craighead WE, Dunlop BW, Nemeroff CB, Keller M, Klein DN, Arnow BA, Husain N, Jarrett RB, Vittengl JR, Menchetti M, Parker G, Barber JP, Bastos AG, Dekker J, Peen J, Keck ME, Kopf-Beck J, BMC medicine 2020 Jun 18 1 170
Acute phase cognitive therapy for recurrent major depressive disorder: Who drops out and how much do patient skills influence response?
Jarrett RB, Minhajuddin A, Kangas JL, Friedman ES, Callan JA, Thase ME Behaviour research and therapy 2013 Jan 51 4-5 221-230
The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis.
Boschloo L, Bekhuis E, Weitz ES, Reijnders M, DeRubeis RJ, Dimidjian S, Dunner DL, Dunlop BW, Hegerl U, Hollon SD, Jarrett RB, Kennedy SH, Miranda J, Mohr DC, Simons AD, Parker G, Petrak F, Herpertz S, Quilty LC, John Rush A, Segal ZV, Vittengl JR, Schoevers RA, Cuijpers P, World psychiatry : official journal of the World Psychiatric Association (WPA) 2019 Jun 18 2 183-191
Do patients' cognitive therapy skills predict personality change during treatment of depression?
Vittengl JR, Clark LA, Thase ME, Jarrett RB, Behaviour research and therapy 2020 Jul 133 103695
Development of a Novel Adult Congenital Heart Disease-Specific Patient-Reported Outcome Metric.
Cedars AM, Ko JM, John AS, Vittengl J, Stefanescu-Schmidt AC, Jarrett RB, Kutty S, Spertus JA, Journal of the American Heart Association 2020 May e015730
Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study.
Schesing KB, Chia R, Elwood B, Halm EA, Lee SJC, Lodhi H, Wu B, Sharma S, Smith SA, Jarrett RB, Das SR, Vongpatanasin W, BMJ open 2020 Nov 10 11 e039940
Quality of life after response to acute-phase cognitive therapy for recurrent depression.
Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB, Journal of affective disorders 2020 Sep 278 218-225
Relations of Shared and Unique Components of Personality and Psychosocial Functioning to Depressive Symptoms.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Journal of personality disorders 2017 Sep 1-26
Partner criticism during acute-phase cognitive therapy for recurrent major depressive disorder.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Behaviour research and therapy 2019 Feb 113 48-56
Could Treatment Matching Patients' Beliefs About Depression Improve Outcomes?
Vittengl JR, Clark LA, Thase ME, Jarrett RB, Behavior therapy 2019 Jul 50 4 765-777
Changes in cognitive content during and following cognitive therapy for recurrent depression: substantial and enduring, but not predictive of change in depressive symptoms.
Jarrett RB, Vittengl JR, Doyle K, Clark LA Journal of consulting and clinical psychology 2007 Jun 75 3 432-46
Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo.
Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME JAMA psychiatry (Chicago, Ill.) 2013 Sep
Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Behaviour research and therapy 2016 Aug 87 48-57
Inodilation--the way ahead in the early therapy of congestive heart failure?
Opie LH, Cardiology 1988 75 Suppl 1 138-47
Estimating outcome probabilities from early symptom changes in cognitive therapy for recurrent depression.
Vittengl JR, Clark LA, Thase ME, Jarrett RB, Journal of consulting and clinical psychology 2019 Apr
Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking.
Furukawa TA, Reijnders M, Kishimoto S, Sakata M, DeRubeis RJ, Dimidjian S, Dozois DJA, Hegerl U, Hollon SD, Jarrett RB, Lespérance F, Segal ZV, Mohr DC, Simons AD, Quilty LC, Reynolds CF, Gentili C, Leucht S, Engel RR, Cuijpers P, Epidemiology and psychiatric sciences 2019 Mar 1-13
Is sleep disturbance linked to short- and long-term outcomes following treatments for recurrent depression?
Boland EM, Vittengl JR, Clark LA, Thase ME, Jarrett RB, Journal of affective disorders 2019 Oct
Do Cognitive Therapy Skills Neutralize Lifetime Stress to Improve Treatment Outcomes in Recurrent Depression?
Vittengl JR, Stutzman S, Atluru A, Jarrett RB, Behavior therapy 2020 Sep 51 5 739-752
Assessing Cognitive Therapy Skills Comprehension, Acquisition, and Use by Means of an Independent Observer Version of the Skills of Cognitive Therapy (SoCT-IO).
Brown GK, Thase ME, Vittengl JR, Borman PD, Clark LA, Jarrett RB Psychological assessment 2015 Sep
The Role of Dyadic Discord in Outcomes in Acute Phase Cognitive Therapy for Adults With Recurrent Major Depressive Disorder.
Trombello JM, Vittengl JR, Denton WH, Minhajuddin A, Thase ME, Jarrett RB, Behavior therapy 2019 Jul 50 4 778-790
Is there a role for continuation phase cognitive therapy for depressed outpatients?
Jarrett RB, Basco MR, Risser R, Ramanan J, Marwill M, Kraft D, Rush AJ Journal of consulting and clinical psychology 1998 Dec 66 6 1036-40
Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
Vittengl JR, Clark LA, Thase ME, Jarrett RB Psychotherapy (Chicago, Ill.) 2015 Jun 52 2 268-77
Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
Vittengl JR, Anna Clark L, Thase ME, Jarrett RB Psychiatry research 2017 Mar 253 174-181
Patients' comprehension and skill usage as a putative mediator of change or an engaged target in cognitive therapy: Preliminary findings.
Jarrett RB, Vittengl JR, Clark LA, Thase ME Journal of affective disorders 2017 Sep 226 163-168
Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
Jarrett RB, Thase ME Contemporary clinical trials 2010 Jul 31 4 355-77
Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC Archives of general psychiatry 1999 May 56 5 431-7
Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.
Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Rush AJ, Segal ZV, Siddique J, Simons AD, Cuijpers P The American journal of psychiatry 2016 Feb appiajp201515040492
Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial.
Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC Archives of general psychiatry 2001 Apr 58 4 381-8
Prophylactic Cognitive Therapy for Major Depressive Disorder.
Jarrett, R. B., & Kraft, D. In Session:Psychotherapy in Practice 1997 3 3 65-79
Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression.
Vittengl JR, Clark LA, Kraft D, Jarrett RB Psychological medicine 2005 May 35 5 693-704
Quantifying and Qualifying the Preventive Effects of Acute-Phase Cognitive Therapy: Pathways to Personalizing Care.
Jarrett RB, Minhajuddin A, Vittengl JR, Clark LA, Thase ME Journal of consulting and clinical psychology 2015 Dec
Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
Vittengl JR, Clark LA, Smits JAJ, Thase ME, Jarrett RB Journal of affective disorders 2019 Jan 242 150-158
Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.
Kennard BD, Stewart SM, Hughes JL, Jarrett RB, Emslie GJ Cognitive and behavioral practice 2008 Nov 15 4 387-399
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB Journal of the American Academy of Child and Adolescent Psychiatry 2008 Dec 47 12 1395-404
Reducing relapse in depressed outpatients with atypical features: a pilot study.
Jarrett RB, Kraft D, Schaffer M, Witt-Browder A, Risser R, Atkins DH, Doyle J Psychotherapy and psychosomatics 2000 Sep-Oct 69 5 232-9
Skills of Cognitive Therapy (SoCT): A new measure of patients' comprehension and use.
Jarrett RB, Vittengl JR, Clark LA, Thase ME Psychological assessment 2011 Feb 578-86
- Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry.
- Mood and related disorders
- Evidence-based psychotherapy
- Cognitive-behavioral therapy
- Psychosocial factors and interventions that promote health
- Cognitive Behavior Therapy for Pain